InspireMD Newsroom

Press Release: InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors

Dow JonesNov 26 05:05

Express News | InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors

BreakingsNov 26 05:05

InspireMD Third Quarter 2024 Earnings: US$0.16 Loss per Share (Vs US$0.15 Loss in 3Q 2023)

Yahoo FinanceNov 14 18:17

InspireMD Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.

BenzingaNov 14 02:16

InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges

TipRanksNov 13 14:01

InspireMD | 10-Q: Q3 2024 Earnings Report

SECNov 13 01:00 · Announcements

InspireMD Achieves Record Q3 Revenue With CGuard Success

TipRanksNov 13 00:16

InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 12 23:24 · Conference Call

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates

Zacks Nov 12 20:35

Express News | InspireMD Q3 Operating Expenses USD 8.876 Million

BreakingsNov 12 20:00

Express News | InspireMD Q3 Gross Profit USD 414 Thousand

BreakingsNov 12 20:00

Express News | InspireMD Q3 Basic EPS USD -0.16

BreakingsNov 12 20:00

InspireMD 3Q Rev $1.81M >NSPR

Dow JonesNov 12 20:00

Press Release: InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

Dow JonesNov 12 20:00

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 9 06:30

Express News | InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsNov 9 06:30

Press Release: InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow JonesNov 9 06:30

InspireMD (NSPR.US) will release financial report before market open on November 12th.

$inspiremd (nspr.us)$ will release its financial report before the market opens on November 12th, investors are invited to pay attention. How was the previous performance? $inspiremd (nspr.us)$ had revenue of 1.739 million USD, net income of -7.909 million USD, and eps of -0.22 USD in 2024/Q2. In 2023/Q3, revenue was 1.556 million USD, net income was -5.178 million USD, and eps was -0.15 USD. The above data is based on the US_GAAP accounting standards. Futubull reminder: 1. Hong Kong and US-listed companies

Futu NewsNov 7 09:00

Express News | InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12TH

BreakingsNov 4 21:00

One InspireMD Insider Raised Stake By 13% In Previous Year

Yahoo FinanceOct 21 21:34